The global metastatic castration-sensitive prostate cancer treatment market is experiencing significant growth. This boom can be credited to factors such as an aging population, escalating prevalence of prostate cancer, and developments in treatment choices. The market is further driven by enhanced knowledge about the disease and its therapy opt… Read More